No takes yet. Share an insight, caveat, or question.
This review highlights metabolomics advancements in understanding lung cancer, indicating potential biomarkers for early diagnosis.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: